|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: Tamoxifen and endometrial changesFrom: dahmd@gate.netWed Oct 2 22:25:36 1996
In article cj7620@cub.uca.edu writes:
>How do you follow a premenopausal patient with an elevated My first question would be why she got a CA125 in the first place. I would imagine it must be due to a family history of ovarian cancer. To my knowledge, CA125 levels do not have much value in premenopausal patients, and have not been proved to be a good screening method in either pre- or post-menopausal patients. I also realize there are studies under way on this issue, and if I am mistaken, would welcome the opportunity to be educated (or, as we said during residency "Thank you Sir, I'll have another"). I have seen some very nice women get perfectly normal reproductive organs removed because of elevated premenopausal CA125 levels that were obtained because of an endometrioma or other benign ovarian cyst. I would follow her with "annual screening", which would consist entirely of a bimanual pelvic exam right after I did her pap smear! Thanks, Ashley Hill D. Ashley Hill, M.D. dahmd@gate.net Orlando, FL Thanks,
>Carole Jackson
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Dec 2 05:17:29 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.